Acurx pharmaceuticals, inc. to discuss fourth quarter and full year 2023 financial results on march 18, 2024 conference call and provide business update

Staten island, n.y. , march 4, 2024 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the company will release its fourth quarter and full year 2023 financial results on monday, march 18, 2024, at 8:00 am et before the u.s. financial markets open.
ACXP Ratings Summary
ACXP Quant Ranking